-
Louis's Most Recent
Articles
Mind Medicine’s Bad Trip Won’t End Anytime Soon
Trouble abounds as Mind Medicine proposes a huge sale of MNMD stock shares and an activist investor threatens the company's board.
Why You Shouldn’t Worry About Fed Chair Powell’s Hawkish Speech
This was a big week for Wall Street, not just because of the slew of earnings reports that were released, but because of the all-important November Federal Open Market Committee (FOMC) statement.
Why SQM Stock Is a Perfect Fit for All Investors
Given its many positives, now may be the perfect time to lock down a long-term position in SQM stock.
This Is No Time to Hit the ‘Buy’ Button With BABA Stock
BABA stock might look like a bargain, but be careful as a third-term Chinese president might not bode well for Alibaba's bottom line.
Bet on the Lithium Boom With Lithium Americas Stock
Although risky, the prospect of going from zero to billions in revenue, as this miner taps into burgeoning lithium demand, makes LAC stock a speculative buy for investors bullish on the trend.
Quant Ratings Updated on 113 Stocks
And as I discussed in last Friday’s Market 360, big earnings misses from Alphabet, Amazon and Meta Platforms triggered huge selloffs in the stocks. Apple’s shares were the only ones to rally after the company reported record sales and net income.
Bet on the Long-Term Bull Case With Livent Stock
The market's current doubtfulness has possibly created an ideal long-term entry point for LTHM stock.
Weekly Upgrades and Downgrades
During these busy times, it pays to stay on top of the latest profit opportunities. And today's blog post should be a great place to start. After taking a close look at the latest data on institutional buying pressure and each company's fundamental health, I decided to revise my Portfolio Grader recommendations for 113 big blue chips. Chances are that you have at least one of these stocks in your portfolio, so you may want to give this list a skim and act accordingly.
A New Study Makes Cassava Sciences Stock an Interesting Buy
Making progress with what could ultimately be a breakthrough treatment, consider SAVA stock a great speculative buy, whether now, or on further weakness.
Expand Your Metals-Friendly Portfolio with Lithium Americas Stock
LAC stock could recharge very soon as Lithium Americas collaborates to address a crucial supply-chain problem.
Energy Companies Report Blowout Earnings
As someone who’s been very bullish on the energy sector this year, I’ve been watching earnings closely. And a few big energy giants – Shell plc (SHEL), Chevron Corporation (CVX), and Exxon Mobil Corporation (XOM) – reported their earnings this week. So, in today’s Market 360, let’s see how their numbers stack up.
FAANG Stocks Get Hit on Earnings – Should You Buy the Dip?
A couple of the FAANGs have changed their names in recent years – Google to Alphabet Inc. (NASDAQ:GOOG) and Facebook to Meta Platforms Inc. (NASDAQ:META) – so the acronym doesn’t work anymore. And the MAANAs doesn’t have quite the same ring to it. Neither do the stocks. Once the market’s highflyers and Wall Street’s darlings, these five tech giants have taken a beating this year. Only Apple’s 18% decline beats the Nasdaq’s 30% loss.
A Deep Dive Into MSFT’s and KO’s Earnings
In today’s Market 360, we’re going to take a look at two big earnings reports this week: Microsoft and The Coca-Cola Company (KO).
Has The Story Changed With TSLA Stock? Not So Fast.
For now, TSLA stock could keep sputtering. Yet as there's still plenty on the table to keep it in high-growth mode, if you've been waiting to buy, now may be the time to do so.
Steal Some Yield and Bet on Clinical Clout With ABBV Stock
ABBV stock investors can collect dividend payments but also expect share-price upside as AbbVie continues to clear regulatory hurdles.
GameStop Gossip Makes GME Stock One to Watch
While the time to add GME stock to your portfolio, keep it on your watchlist. Shares could fall to a price where the stock's merits as a turnaround play become highly-favorable from a risk/reward standpoint. With this, the opportunity to make the stock a speculative buy could emerge.
